Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00410605
Status:
COMPLETED
Last Update Posted:
2017-09-01
First Post:
2006-12-11
Brief Title:
Bevacizumab Lenalidomide and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage III Multiple Myeloma |
| Multiple Myeloma in Relapse |
| Stage II Multiple Myeloma |
Keywords: